Literature DB >> 8610450

Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species.

P P Mertens1, J N Burroughs, A Walton, M P Wellby, H Fu, R S O'Hara, S M Brookes, P S Mellor.   

Abstract

Previous studies (Mertens et al., Virology 157, 375-386, 1987) have shown that removal of the outer capsid layer from bluetongue virus (BTV) significantly reduces (approximately x 10(-4)) the infectivity of the resultant core particle for mammalian cells (BHK 21 cells). In contrast, the studies reported here, using a cell line (KC cells) derived from a species of Culicoides that can act as a vector for BTV (Culicoides variipennis), demonstrated a much higher infectivity of core particles than that in mammalian cells (approximately x 10(3)). This increase resulted in a specific infectivity for cores that was only 20-fold less than that of purified disaggregated virus particles (stored in the presence of 0.1% sodium-N-lauroylsarcosine (NLS)). Removal of this detergent caused intact virus particle aggregation and (as previously reported) resulted in an approximately 1 log10 drop in the specific infectivity of those virus particles which remained in suspension. In consequence the specific infectivity of core particles for the KC cells was directly comparable to that of the intact but aggregated virus. These data are compared with the results from oral infectivity studies using two vector species (C. variipennis and Culicoides nubeculosus), which showed similar infection rates at comparable concentrations of purified cores, or of the intact but aggregated virus particles (NLS was toxic to adult flies). The role of the outer core proteins (VP7) in cell attachment and penetration, as an alternative route of initiation of infection, is discussed. Previous studies (Mertens et al., Virology 157, 375-386, 1987) also showed that the outer capsid layer of BTV can be modified by proteases (including trypsin or chymotrypsin), thereby generating infectious subviral particles (ISVP). The specific infectivity of ISVP for mammalian cells (BHK21 cells) was shown to be similar to that of disaggregated virus particles. In contrast, we report a significantly higher specific infectivity of ISVP but not of the intact virus (approximately x 100) for two insect cell lines (KC cells and C6/36 mosquito cells (derived from Aedes albopictus)). In oral infection studies with adults of the two vector species, ISVP produced the same infection rate at approximately 100-fold lower concentrations than either core particles or the intact but aggregated virus particles. The importance of mammalian host serum proteases, or insect gut proteases, in modification of the intact virus particle to form ISVP and their role in initiation of infection and the vector status of the insect is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610450     DOI: 10.1006/viro.1996.0153

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins mu1 and sigma3.

Authors:  K Chandran; S B Walker; Y Chen; C M Contreras; L A Schiff; T S Baker; M L Nibert
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry.

Authors:  S S Hassan; P Roy
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.

Authors:  B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; P Roy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.

Authors:  Andrew R Beaton; Javier Rodriguez; Y Krishnamohan Reddy; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

5.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

6.  A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.

Authors:  Sarah Gold; Paul Monaghan; Peter Mertens; Terry Jackson
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

7.  Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: infection initiated by a small number of susceptible epithelial cells and a population bottleneck.

Authors:  Darci R Smith; A Paige Adams; Joan L Kenney; Eryu Wang; Scott C Weaver
Journal:  Virology       Date:  2007-11-19       Impact factor: 3.616

8.  The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti.

Authors:  Doug E Brackney; Brian D Foy; Ken E Olson
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

Review 9.  Adaptive strategies of African horse sickness virus to facilitate vector transmission.

Authors:  Anthony Wilson; Philip Scott Mellor; Camille Szmaragd; Peter Paul Clement Mertens
Journal:  Vet Res       Date:  2008-12-19       Impact factor: 3.683

10.  Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland.

Authors:  Martin A Hofmann; Sandra Renzullo; Markus Mader; Valérie Chaignat; Gabriella Worwa; Barbara Thuer
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.